Aytu BiopharmaAYTU
13F holders, Q2 2025 (June 30)32holders +1
7new positions
5sold out
1famous investor
$2.18avg. 13F price*
At the end of Q2 2025, 32 institutions reported holding Aytu Biopharma Inc. (AYTU) in their 13F filings, up 1 from Q1 2025. 7 opened new positions and 5 sold out. The largest holders were Nantahala Capital Management, LLC ($2.4M), Stonepine Capital Management, LLC ($1.8M) and AWM Investment Company, Inc. ($1.4M). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Aytu Biopharma Inc.
- CUSIP
- 054754858
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 7 | $2.8M |
| Exits | 5 | $124K |
All 13F filers, Q1 2025 → Q2 2025: 1,649,215 shares bought and 109,635 shares sold, net +1,539,580 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 32 holders
| Nantahala Capital Management, LLC | 0.17% | No change | 1,086,812 | $2.4M |
| Stonepine Capital Management, LLC | 1.75% | Add +75.3% | 812,676 | $1.8M |
| AWM Investment Company, Inc. | 0.15% | New | 619,874 | $1.4M |
| Kanen Wealth Management LLC | 0.48% | New | 573,358 | $1.2M |
| Renaissance Technologies | 0.00% | Add +17.0% | 89,913 | $196K |
| Geode Capital Management, LLC | 0.00% | Reduce -0.1% | 53,869 | $117K |
| FNY Investment Advisers, LLC | 0.03% | New | 35,921 | $78K |
| Two Sigma Investments, LP | 0.00% | New | 35,035 | $76K |
| Vanguard Group Inc. | 0.00% | No change | 27,888 | $61K |
| BlackRock, Inc. | 0.00% | No change | 22,793 | $50K |
| HRT Financial LP | 0.00% | New | 19,988 | $43K |
| Jaffetilchin Investment Partners, LLC | 0.00% | No change | 17,437 | $38K |
| Acadian Asset Management LLC | 0.00% | Reduce -30.0% | 10,237 | $22K |
| MAI Capital Management | 0.00% | No change | 3,575 | $8K |
| UBS Group AG | 0.00% | Add +1063.0% | 3,047 | $7K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -45.9% | 2,538 | $6K |
| Osaic Holdings, Inc. | 0.00% | No change | 300 | $654 |
| Morgan Stanley | 0.00% | Reduce -1.4% | 286 | $624 |
| SBI Securities Co., Ltd. | 0.00% | Add +245.9% | 211 | $460 |
| Wells Fargo & Company | 0.00% | Add +2.4% | 127 | $277 |
| CIBC Private Wealth Group LLC | 0.00% | No change | 83 | $181 |
| Bank of America Corp. | 0.00% | Reduce -38.8% | 63 | $137 |
| Raymond James Financial Inc. | 0.00% | New | 55 | $120 |
| Group One Trading LLC | 0.00% | No change | 37 | $81 |
| BNP Paribas Financial Markets | 0.00% | No change | 23 | $50 |
| NewEdge Advisors, LLC | 0.00% | No change | 21 | $46 |
| Moser Wealth Advisors, LLC | 0.00% | No change | 10 | $22 |
| Vision Financial Markets LLC | 0.00% | No change | 2 | $5 |
| Barclays PLC | 0.00% | No change | 1 | $2 |
| Jones Financial Companies LLLP | 0.00% | Reduce -91.7% | 1 | $2 |
| Northwestern Mutual Wealth Management Co. | 0.00% | New | 1 | $2 |
| Tsfg, LLC | 0.00% | No change | 1 | $0 |
"% of holder's portfolio" is AYTU's weight in each manager's 13F, not the share of Aytu Biopharma Inc. the manager owns.